---
title: Joshua Schiffman
date_tdt: 2018-12-11T20:06:08.785Z
author: Sarah Thomas
layout: default
permalink: /partners_investigators/
published: true
isPublic_b: true
type_txt: x01-investigator
name_txt: Joshua Schiffman
link_txt: ''
logoRef_txt: __images/29d4bbe0-fd87-11e8-ac41-b99f4919a8fd.md
description_txt: ''
readMoreButton_txt: Read More
order_ti: 5
almaMater_txt: University of Utah
researchFocus_txt: ''
quote_txt: ''

---



Dr. Schiffman received his medical degree from Brown University School of Medicine, completed his Pediatric Residency, Pediatric Chief Residency, and Pediatric Hematology/Oncology Fellowship at Stanford University. He has been an investigator at the Huntsman Cancer Institute since 2008, and a faculty member at the University of Utah since 2009. Dr. Schiffman is board-certified in Pediatrics and Pediatric Hematology-Oncology.

He is currently a Professor of Pediatrics at the University of Utah, an Adjunct Professor in the Department of Oncological Sciences, and is in the Division of Hematology/Oncology at Primary Children´s Medical Center. He serves as the Medical Director of the High Risk Pediatric Cancer Clinic at Huntsman Cancer Institute where he cares for children and families with inherited risk for cancer. His specific clinical interests are cancer susceptibility in families, with a focus on the genomic changes necessary for cancer development.

Dr. Schiffman’s work in the High Risk Pediatric Cancer Clinic contributed to a landmark study in the field of clinical cancer genetics demonstrating that early cancer surveillance in families with Li-Fraumeni Syndrome significantly improves overall survival. He continues to work with children and families at high risk for cancer development to discover genes that may be targeted for both prevention and treatment of childhood cancer. Dr. Schiffman is also the Education Director for the Program in Personalized Health Care at the University of Utah, where he oversees the teaching of personalized medicine to physicians and their patients.


